NEW YORK (GenomeWeb News) – PerkinElmer this week announced the establishment of direct operations in Israel, headquartered near Tel Aviv. Through its new Israel base, PerkinElmer will commercialize and support its life sciences and technologies, analytical sciences, and laboratory services business offerings.

The company's board separately last week declared a quarterly dividend of $.07 per share, payable on Nov. 8 to shareholders of record at the close of business on Oct. 18.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.